Journal article icon

Journal article

Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial

Abstract:

BACKGROUND: Early detection and treatment of asymptomatic men with advanced and high-risk prostate cancer (PCa) may improve survival rates. OBJECTIVE: To determine outcomes for men diagnosed with advanced PCa following prostate-specific antigen (PSA) testing who were excluded from the ProtecT randomised trial. DESIGN, SETTING, AND PARTICIPANTS: Mortality was compared for 492 men followed up for a median of 7.4 yr to a contemporaneous cohort of men from the UK Anglia Cancer Network (ACN) and w...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1016/j.eururo.2016.09.040

Authors


Johnston, TJ More by this author
Parashar, D More by this author
Greenberg, D More by this author
Expand authors...
Cancer Research UK More from this funder
Publisher:
Elsevier Publisher's website
Journal:
European Urology Journal website
Volume:
71
Issue:
3
Pages:
381-388
Publication date:
2016-10-06
Acceptance date:
2016-09-26
DOI:
EISSN:
1873-7560
ISSN:
0302-2838
Pubs id:
pubs:653521
URN:
uri:feb2cc6f-86e4-4af1-b7c1-a28815ccfae1
UUID:
uuid:feb2cc6f-86e4-4af1-b7c1-a28815ccfae1
Local pid:
pubs:653521
Paper number:
3

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP